Not sure if this is old news or not. Looked back a little and didn't see anything on his MSK study.
It has been showing up here and there over the last few months. Most of these patients were on Pembro and were probably part of keynote 006 trial. Would be nice if all of the Pd-1 patients data went into some kind of central Bristol Myer Squibb system or Merck system and they actual shared the information to keep us all up to date!!! Maybe some day drug companies will be responsible for recording survival past the trials and into the real world. Thanks for posting!!!Ed
Every hour one American dies from melanoma.
Donate what you can
Your donation can save lives. Thank you!
Your tax-deductible donation can make a difference.